Market Research Report
Latin America, Middle East & Africa Spinal Cord Stimulation Devices Market (2019-2025)
|Latin America, Middle East & Africa Spinal Cord Stimulation Devices Market (2019-2025)|
Published: September 30, 2019
Content info: 72 Pages
Delivery time: 1-2 business days
The Latin America, Middle East and Africa Spinal Cord Stimulation Devices Market would witness market growth of 9.06% CAGR during the forecast period (2019-2025). The growing amount of chronic and neuropathic pains in patients and the simultaneous introduction of new products by leading companies is further pushing the industry growth.
Spinal cord stimulation is referred to as a neuro-stimulation treatment that cures specific pain conditions like chronic pain. The stimulation process uses stimulators to block the pain signals before they reach the brain. A stimulator device is implanted under the patients' skin and it sends electric signals to the specified areas of the spinal cord for treating the pain. When the stimulator device is switched on, it modifies the pain signal that travels to the brain. It contains a small wire which carries electrical signals to transmit it towards the nerve fibers of a spinal cord. With this capability, spinal cord stimulation devices can effectively help to reduce the pain due to electrical pulses and mask the pain signal from reaching the patient's brain.
Based on Product, the market is segmented into Rechargeable and Non-Rechargeable. Based on Application, the market is segmented into Complex Regional Pain Syndrome, Unsuccessful Disk Surgery, Failed Back Syndrome, Degenerative Disk Disease and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories (St. Jude Medical, Inc.), Neurosigma, Inc., Nevro Corporation, Synapse BioMedical, Inc., Integer Holdings Corporation, Stimwave Technologies, Inc., Nuvectra Corporation and Saluda Medical Pty Ltd.